Fennec Pharmaceuticals Inc (FENC)

R&D to Revenue

0.66%

Quarterly · Period ending:

FENC logo

FENC R&D to Revenue

Latest reported0.66%
FENC Quarterly R&D/Revenue (0.00% → 0.66%)
High-resolution chart · PNG

FENC r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Fennec Pharmaceuticals Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
0.6602%
0.3243%
0.1452%
0.2327%
1.1086%
1.0742%
0.6309%
1.3909%
2.1619%
0.0118%
0.3287%
0.1842%
0.2406%
0.2385%
7.6221%
0%
0%
0%
0%
0%
0%
0%
719.4118%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.